Elstar Therapeutics locks in $39 mln Series A
Cambridge, Massachusetts-based Elstar Therapeutics, a provider of precision cancer immunotherapy, has raised $39 million in Series A financing. The investor was Apple Tree Partners.
3 January 2018•1 min read
